Sustained cellular immune dysregulation in patients recovering from COVID-19

COVID-19, which has killed 1.7 million people worldwide and wrecked economies across the globe, does not follow a uniform path. It is predictably unpredictable and kept scientists on their toes for the past one year. Many infected patients are asymptomatic or display very mild symptoms. Others, especially those with comorbidities, can develop severe clinical disease with atypical pneumonia and multiple system organ failure. Since the first cases were reported in December 2019, the SARS-CoV-2 virus that causes COVID-19 has surged into a pandemic. New cases and deaths are still mounting. Ongoing observational clinical research has become a priority to better understand how this previously unknown virus acts. Also Read – Pfizer, Moderna COVID-19 vaccines safe for people with food allergies, say experts

To better understand the disease, researchers from the University of Alabama at Birmingham have conducted an observational study on “Sustained cellular immune dysregulation in individuals recovering from SARS-CoV-2 infection”. This is published in the Journal of Clinical Investigation. The importance of these studies to provide context for the interpretation of immune responses generated by participants in COVID-19 vaccine trials, including how those responses change over time, cannot be over-emphasized. It holds the key to potential modifications to existing COVID-19 vaccines and treatments. Also Read – Coronavirus: Here’s what you need to know about Oxford COVID-19 vaccine

Understanding the immune system’s response

For the purpose of the study, the UAB researchers obtained blood samples and clinical data from 46 hospitalized COVID-19 patients and 39 non-hospitalized individuals who had recovered from confirmed COVID-19 infection. Both groups were compared to healthy, COVID-19-negative controls. Importantly, most individuals in the hospitalized group had active SAR-CoV-2 viruses in their blood and were in the hospital at the time of sample collection. All individuals in the non-hospitalized group were convalescent at the time of sample collection. Also Read – COVID-19 and Diabetes: Understanding the reasons for worst outcomes

From the blood samples, researchers were able to separate specific immune cell subsets and analyze cell surface markers. From this complex information, immunologists can analyze how each individual’s immune system is responding during infection and during convalescence. Some of these results can reveal whether immune cells have become activated and exhausted by the infection. Exhausted immune cells may increase susceptibility to a secondary infection or hamper development of protective immunity to COVID-19.

Observing changes over time

In addition, the researchers were able to analyze changes over time, in two ways. The first was observing changes in surface markers over time, defined as days since the onset of symptoms for non-hospitalized samples. The second was directly comparing the frequencies of these markers between the first and second clinic visits for non-hospitalized patients who had blood samples collected at two sequential timepoints. The most surprising finding involved non-hospitalized patients. While the UAB researchers saw upregulated activation markers in hospitalized patients, they also found several activation and exhaustion markers were expressed at higher frequencies in non-hospitalized convalescent samples.

Immune dysregulation in non-hospitalised patients

Looking at these markers over time, it was apparent that immune dysregulation in the non-hospitalized individuals did not quickly resolve. Furthermore, the dysregulation of T cell activation and exhaustion markers in the non-hospitalized cohort was more pronounced in the elderly. “To our knowledge,” the researchers reported, “this is the first description of sustained immune dysregulation due to COVID-19 in a large group of non-hospitalized convalescent patients.”

The B and T cells from both patient cohorts had phenotypes consistent with activation and cellular exhaustion throughout the first two months of infection. And in the non-hospitalized individuals, the activation markers and cellular exhaustion increased over time. These findings illustrate the persistent nature of the adaptive immune system changes that have been noted in COVID-19 and suggest longer-term effects that may shape the maintenance of immunity to SARS-CoV-2.

(With inputs from Agencies)

Published : January 1, 2021 3:39 pm

Source: | This article originally belongs to thehealthsite.com

M	T	W	T	F	S	S
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28

Sustained cellular immune dysregulation in patients recovering from COVID-19

Up next

Wycombe Wanderers: Transfer ins and outs – January 2021

Author

247 News Around The World

Preview, Where to watch, Schedule, Dates, Seeds, Prize Money, Live Streaming details

Rep. Mike Rogers offers succinct GOP assessment of Chinese spy flight